Top Markets
#1 Islamic Coin Islamic Coin +151.48%
#2 DOVU DOVU +48.81%
#3 Black Phoenix Black Phoenix +34.68%
#4 Velvet Velvet +30.25%
#5 Cross Cross +21.75%
#6 Akedo Akedo +18.18%
#7 DoubleZero DoubleZero +14.26%
#8 Cap Cap +11.23%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.05%
#10 HOME HOME +11.00%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Fabino Enterprises Ltd Fabino Enterprises Ltd

Fabino Enterprises Ltd

FABINO
Rangering i aksjer #39501
Operating from its Sonipat, India base since its incorporation in 2011, Fabino... Operating from its Sonipat, India base since its incorporation in 2011, Fabino Enterprises Limited is engaged in the manufacturing, marketing, trading, and packaging of pharmaceutical and wellness-oriented consumer products throughout India. Its extensive product portfolio, marketed under the Fabino and Keepshine brands, includes allopathic and select herbal medications—such as tablets, ointments, and syrups—along with various food and general wellness items. The company also extends its reach globally by exporting wellness and Fast-Moving Consumer Goods (FMCG) like coffee, malt powder, protein powder, and hair shampoo. Fabino's products are distributed and promoted via its own robust internal network and specialized sales force. Notably, the entity adopted its current name, Fabino Enterprises Limited, in June 2024, having previously been known as Fabino Life Sciences Limited.
Aksjekurs
$0.22413867
Sist synkronisert: 2026-05-25
Markedsverdi
$463.14K
Endring (1 dag)
0.00%
Endring (1 år)
-24.40%
Land
IN
Handel Fabino Enterprises Ltd (FABINO)

Kategori

Healthcare
P/E-forhold for Fabino Enterprises Ltd (FABINO)
P/E-forhold per 2026 TTM: 0
Ifølge Fabino Enterprises Ltd sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for Fabino Enterprises Ltd fra 2026 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
Ikke nok data for de angitte datoene.
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 23.71 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 220.17 -
US
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.